Heme inhibits human neutrophil apoptosis: Involvement of phosphoinositide 3-kinase, MAPK, and NF-κB

Journal of Immunology

Volumn 173, Issue 3, 2004, Pages 2023-2030

  Arruda, Maria Augusta ^a   Rossi, Adriano G ^c   De Freitas, Marta S ^a   Barja Fidalgo, Christina ^a   Graça Souza, Aurélio V ^b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEME; HEME OXYGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; HEMOGLOBINOPATHY; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOLOGY; IN VITRO STUDY; LONGEVITY; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

EID: 3242741986     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.3.2023     Document Type: Article

References (55)

1. Muller-Eberhard, U., and M. Fraig. 1993. Bioactivity of heme and its containment. Am. J. Hematol. 42:59.
2. Reiter, C. D., X. Wang, J. E. Tanus-Santos, N. Hogg, R. O. Cannon III, A. N. Schechter, and M. T. Gladwin. 2002. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8:1383.
3. Graça-Souza, A. V., M. A. Arruda, M. S. de Freitas, C. Barja-Fidalgo, and P. L. Oliveira. 2002. Neutrophil activation by heme: implications for inflammatory processes. Blood 99:4160.
4. Haeger, M., M. Unander, B. Andersson, A. Tarkowski, J. P. Arnestad, and A. Bengtsson. 1996. Increased release of tumor necrosis factor-α and interleukin-6 in women with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Acts Obstet. Gynecol. Scand. 75:695.
5. Davenport, R. D., R. M, Stricter, T. J. Standiford, and S. L. Kunkel. 1990. Interleukin-8 production in red blood cell incompatibility. Blood 76:2439.
6. Davenport, R. D., and S. L. Kunkel. 1994. Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Transfus. Med. Rev. 8:157.
7. 2 in sickle cell disease. Blood 91:3423.
8. Gonçalves, M. S., I. L. Queiroz, S. A. Cardoso, A. Zanetti, A. C. Strapazoni, E. Adorno, A. Albuquerque, A. Sant'Ana, M. G. dos Reis, A. Barral, and M. Barral Netto. 2001. Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease. Braz. J. Med. Biol. Res. 34:1309.
9. Wun, T. 2001. The role of inflammation and leukocytes in the pathogenesis of sickle cell disease; haemoglobinopathy. Hematology 5:403.
10. Kaul, D. K., and R. P. Hebbel. 2000. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J. Clin. Invest. 106:411.
11. Savill, J. 1997. Apoptosis in resolution of inflammation. J. Leukocyte Biol. 61:375.
12. Ward, C., I. Dransfield, E. R. Chilvers, C. Haslett, and A. G. Rossi. 1999. Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol. Sci. 20:503.
13. Edwards, S. W. 2000. Biochemistry and Physiology of the Neutrophil. Cambridge University Press, New York.
14. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2:965.
15. Hengartner, M. O. 2000. The biochemistry of apoptosis. Nature 407:770.
16. Kettritz, R., M. L. Gaido, H. Haller, F. C. Luft, C. J. Jennette, and R. J. Falk. 1998. Interleukin-8 delays spontaneous and tumor necrosis factor-α-mediated apoptosis of human neutrophils. Kidney Int. 53:84.
17. Lee, A., M. K. Whyte, and C. Haslett. 1993. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukocyte Biol. 54:283.
18. Colotta, F., F. Re, N. Polentarutti, S. Sozzani, and A. Mantovani. 1992. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012.
19. Hebert, M. J., T. Takano, H. Holthofer, and H. R. Brady. 1996. Sequential morphologic events during apoptosis of human neutrophils: modulation by lipoxygenase-derived eicosanoids. J. Immunol. 157:3105.
20. Klein, J. B., M. J. Rane, J. A. Scherzer, P. Y. Coxon, R. Kettritz, J. M. Mathiesen, A. Buridi, and K. R. McLeish. 2000. Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J. Immunol. 16:4286.
21. Klein, J. B., A. Buridi, P. Y. Coxon, M. J. Rane, T. Manning, R. Kettritz, and K. R. McLeish. 2001. Role of extracellular signal-regulated kinase and phosphatidylinositol-3 kinase in chemoattractant and LPS delay of constitutive neutrophil apoptosis. Cell. Signal. 13:335.
22. Ward, C., E. R. Chilvers, M. F. Lawson, J. G. Pryde, S. Fujihara, S. N. Farrow, C. Haslett, and A. G. Rossi. 1999. NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro. J. Biol. Chem. 274:4309.
23. Akgul, C., D. A. Moulding, and S. W. Edwards. 2001. Molecular control of neutrophil apoptosis. FEBS Lett. 487:318.
24. Boyum, A. 1976. Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol. (Suppl. 5):9.
25. Fierro, I. M., C. Barja-Fidalgo, R. M. Canedo, F. Q. Cunha, and S. H. Ferreira. 1995. An increase in nitric oxide produced by rat peritoneal neutrophils is not involved in cell apoptosis. Mediat. Inflamm. 4:222.
26. Coelho, A. L., M. S. De Freitas, A. Mariano-Oliveira, A. L. Oliveira-Carvalho, R. B. Zingali, and C. Barja-Fidalgo. 2001. Interaction of disintegrins with human neutrophils induces cytoskeleton reorganization, focal adhesion kinase activation, and extracellular-regulated kinase-2 nuclear translocation, interfering with the chemotactic function. FASEB J. 15:1643.
27. Bradford, M. 1976. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
28. Fadeel, B., A. Ahlin, J. I. Henter, S. Orrenius, and M. B. Hampton. 1998. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 92:4808.
29. Ferran, C., D. M. Stroka, A. Z. Badrichani, J. T. Cooper, C. J. Wrighton, M. Soares, S. T. Grey, and F. H. Bach. 1998. A20 inhibits NF-κB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 91:2249.
30. Caamano, J., and C. A. Hunter. 2002. NF-κB family of transcription factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 15:414.
31. Zheng, X., A. Karsan, V. Duronio, F. Chu, D. C. Walker, T. R. Bai, and R. R. Schellenberg. 2002. Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-κB-dependent and -independent pathways. Immunology 107:306.
32. Aoshiba, K., Y. Nakajima, S. Yasui, J. Tamaoki, and A. Nagai. 1999. Red blood cells inhibit apoptosis of human neutrophils. Blood 93:4006.
33. Choi, A. M., and J. Alam. 1996. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 15:9.
34. Willoughby, D. A., A. R. Moore, P. R. Colville-Nash, and D. Gilroy. 2000. Resolution of inflammation. Int. J. Immunopharmacol. 22:1131.
35. Wagener, F. A. D. T. G., H. Volk, D. Willis, N. G. Abraham, M. P. Soares, G. J. Adema, and C. G. Figdor. 2003. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev. 55:551.
36. Otterbein, L. E., L. L. Mantell, and A. M. Choi. 1999. Carbon monoxide provides protection against hyperoxic lung injury. Am. J. Physiol. 276:L688.
37. Brouard, S., P. O. Berberat, E. Tobiasch, M. P. Seldon, F. H. Bach, and M. P. Soares. 2002. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-κB to protect endothelial cells from tumor necrosis factor-α-mediated apoptosis. J. Biol. Chem. 277:17950.
38. Soares M. P., M. P. Seldon, I. P. Gregoire, T. Vassilevskaia, P. O. Berberat, J. Yu, T. Y. Tsui, and F. H. Bach. 2004. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J. Immunol. 172:3553.
39. Hockenbery, D. M., Z. N. Oltvai, X. M. Yin, C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241.
40. Hampton, M. B., and S. Orrenius. 1997. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett. 414:552.
41. Hsu, M. J., S. S. Lee, and W. W. Lin. 2002. Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. J. Leukocyte Biol. 72:207.
42. Watson, R. W. 2002. Redox regulation of neutrophil apoptosis. Antioxid. Redox Signal. 4:97.
43. Martin, M. C., I. Dransfield, C. Haslett, and A. G. Rossi. 2001. Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway. J. Biol. Chem. 276:45041.
44. Pongracz, J., P. Webb, K. Wang, E. Deacon, O. J. Lunn, and J. M. Lord. 1999. Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-δ. J. Biol. Chem. 274:37329.
45. Cross, T. G., D. Schell-Toellner, N. V. Henriquez, E. Deacon, M. Salmon, and J. M. Lord. 2000. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256:34.
46. Lentsch, A. B., and P. A. Ward. 1999. Activation and regulation of NF-κB during acute inflammation. Clin. Chem. Lab. Med. 37:205.
47. Baldwin, A. S., Jr. 2001. Series introduction: the transcription factor NF-κB and human disease. J. Clin. Invest. 107:3.
48. Yamamoto, Y., and R. B. Gaynor. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107:135.
49. Barkett, M., and T. D. Gilmore. 1999. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18:6910.
50. Aggarwal, B. B. 2000. Apoptosis and NF-κB: a tale of association and dissociation. Biochem. Pharmacol. 60:1033.
51. Vancurova, I., V. Miskolci, and D. Davidson. 2001. NF-κB activation in tumor necrosis factor α-stimulated neutrophils is mediated by protein kinase Cδ: correlation to nuclear IκBα. J. Biol. Chem. 276:19746.
52. Castro-Alcaraz, S., V. Miskolci, B. Kalasapudi, D. Davidson, and I. Vancurova. 2002. NF-κB regulation in human neutrophils by nuclear IκBα: correlation to apoptosis. J. Immunol. 169:3947.
53. Haddad, J. J. 2002. Science review: redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for nuclear factor-κB. Crit. Care 6:481.
54. Asehnoune, K., D. Strassheim, S. Mitra, J. Y. Kim, and E. Abraham. 2004. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB. J. Immunol. 172:2522.
55. Zhang, X., E. L. Bedard, R. Potter, R. Zhong, J. Alam, A. M. Choi, and P. J. Lee. 2002. Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury. Am. J. Physiol. 283:L815.